The Beauty Health Company (SKIN)
$12.36
Rating:
Recommendation:
-
| Symbol | SKIN |
|---|---|
| Price | $12.36 |
| Beta | 1.153 |
| Volume Avg. | 2.09M |
| Market Cap | 1.639B |
| Shares () | - |
| 52 Week Range | 8.25-19.38 |
| 1y Target Est | - |
| DCF Unlevered | SKIN DCF -> | |
|---|---|---|
| DCF Levered | SKIN LDCF -> | |
| ROE | 15.80% | Buy |
| ROA | 4.40% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 488.37% | Strong Buy |
| P/E | -53.74 | Strong Sell |
| P/B | 9.96 | Strong Buy |
Latest SKIN news
About
Download (Excel)The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.